![Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies - ScienceDirect Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S147751311930436X-fx1.jpg)
Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies - ScienceDirect
![PDF) Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: A prospective cohort study with solifenacin PDF) Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: A prospective cohort study with solifenacin](https://i1.rgstatic.net/publication/316176684_Real_life_persistence_rate_with_antimuscarinic_treatment_in_patients_with_idiopathic_or_neurogenic_overactive_bladder_A_prospective_cohort_study_with_solifenacin/links/5964960c0f7e9b81949a6ae4/largepreview.png)
PDF) Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: A prospective cohort study with solifenacin
![Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study | Scientific Reports Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-23795-5/MediaObjects/41598_2022_23795_Fig1_HTML.png)
Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study | Scientific Reports
![Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review - ScienceDirect Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1477513122003795-gr2.jpg)